Table 1.
Summary of demographic and clinical features
| Total (n=59) | |
|---|---|
|
| |
| Age (years) | |
| Median (range) | 14.1 (5.01–23.5) |
| ≤14 | 28 |
| >14 | 31 |
|
| |
| Gender | |
| Female | 26 |
| Male | 33 |
|
| |
| Race | |
| Non-White | 22 |
| White | 37 |
|
| |
| Survival status | |
| Alive | 41 |
| Expired | 18 |
|
| |
| Site of primary tumor | |
| Extremity | 55 |
| Axial | 4 |
|
| |
| Disease at presentation (n=58) | |
| Local, resectable disease | 48 |
| Local, unresectable disease | 1 |
| Metastatic disease | 10 |
|
| |
| Rosen grade* (n=53) | |
| 1 or 2 | 22 |
| 3 or 4 | 31 |
|
| |
| Follow up (years) | |
| Median (range) | 4.4 (0.5–14) |
|
| |
| Outcome (%) | |
| 5-Year overall survival | 63.6 ± 10.3 |
| 5-Year event-free survival | 57.0 ± 10.0 |